Requisition ID: 7507 Grade: ISA-P2 Country: Austria Duty Station: Vienna Category: International Consultant Type of Job Posting: Internal and External Employment Type: Non-staff Regular Contract Duration: 6 months (with the possibility of extension) Application Deadline: 11-Jun-2026,
Internal Job Description To lead Local Study Teams (LSTs) at country level to deliver committed components of clinical studies according to agreed resources, budget and timelines complying with Sponsor Procedural Documents, international guidelines such as ICH-GCP
IQVIA currently offers the exciting opportunity for a (Sr.) Site Activation Specialist (m/w/d) to work in the Country Site Activation Department in our Vienna office Austria. In this role you will perform tasks at a country
The group you’ll be a part of This position is in the Global Products Group, we are dedicated to excellence in the design and engineering of Lams etch and deposition products. We drive innovation to ensure
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description IT System Engineer (m/w/d) Location: Linz/Austria Purposes of the position/responsibilities: We are looking for IT enthusiasts to join our IT team! As System Analyst you will have the oversight
BandLevel 6 Job Description SummaryThe Global Head Sterility Assurance provides strategic leadership for sterility assurance and aseptic quality across the Novartis manufacturing network. This role leads Quality Assurance leaders and Senior Global Aseptic Processing Experts to
Job Description Unsere Produktionsteams setzen sich aus den Menschen zusammen, die unsere Produkte effektiv herstellen. In unseren Produktionsstätten gilt stets die Devise „Safety First, Quality Always“ mit dem Ziel der kontinuierlichen Verbesserung. Als Teil unseres globalen
Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich
CRA Austria Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Our Clinical Development model
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)